Saturday, July 11, 2026

pharma

Bausch & Lomb

Bausch & Lomb drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

AU HQ
TGA registrant Type
Company details
Status
Public
HQ
AU
Programs
0
Drugs
1
Patents
0
Intelligence · Drug Pipeline

Bausch & Lomb pipeline

Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Bausch & Lomb drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

1 compounds
  1. Development asset linked to Bausch & Lomb in public FDA and regional records.